Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
25.85
+0.05 (+0.19%)
Official Closing Price
Updated: 7:00 PM EST, Dec 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks
↗
November 14, 2025
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.
Via
Benzinga
Topics
Artificial Intelligence
AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines
November 14, 2025
The pharmaceutical industry is on the cusp of a profound transformation, driven by the integration of data science and Artificial Intelligence (AI) into drug formulation stability models. This...
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Product Recall
AI Revolutionizes Medicine: Precision Bioanalysis and Targeted Delivery Usher in a New Era of Healthcare
November 14, 2025
The convergence of artificial intelligence (AI) with advanced bioanalysis and targeted drug delivery technologies is fundamentally reshaping the landscape of medicine and healthcare. These synergistic...
Via
TokenRing AI
Topics
Artificial Intelligence
What's going on in today's session: S&P500 most active stocks
↗
November 14, 2025
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for...
Via
Chartmill
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
November 14, 2025
The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since
↗
November 14, 2025
Via
MarketBeat
Why Pfizer (PFE) Shares Are Sliding Today
November 14, 2025
Shares of global pharmaceutical company Pfizer (NYSE:PFE) fell 2.5% in the morning session after the company cut its stake in its pandemic partner BioNTech by more than half, a move that overshadowed...
Via
StockStory
Topics
Artificial Intelligence
Stocks
Supply Chain
Ozempic Maker Novo Nordisk Faces Board Shakeup
↗
November 14, 2025
Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity drug market.
Via
Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
↗
November 14, 2025
Via
Benzinga
Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO
↗
November 14, 2025
The board overhaul follows mass resignations triggered by internal disputes over Novo’s direction.
Via
Stocktwits
Pfizer Stock Slips Premarket Despite Completing Metsera Deal; Investors React To BioNTech Stake Cut
↗
November 14, 2025
The Metsera buyout brings multiple obesity and cardiometabolic drug candidates into Pfizer’s pipeline, including a GLP-1 nearing Phase 3.
Via
Stocktwits
Topics
Intellectual Property
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium
↗
November 13, 2025
Via
Stocktwits
AI Revolutionizes Cardiovascular Clinical Trials: A Leap Towards Cheaper, Faster Drug Development
November 13, 2025
San Francisco, CA – November 13, 2025 – Artificial Intelligence (AI) has achieved a pivotal breakthrough in the medical field, successfully adjudicating clinical events in cardiovascular trials. This...
Via
TokenRing AI
Topics
Artificial Intelligence
Post-Shutdown Jitters: Markets Reel as Government Reopens
November 13, 2025
The United States government, after an unprecedented 43-day shutdown, officially reopened on Thursday, November 13, 2025, as President Donald Trump signed a funding bill into law. While the resolution...
Via
MarketMinute
Topics
Bonds
Economy
Government
Gilead’s Experimental One Pill Regimen Proved Non-Inferior To Multi-Pill Regimens In Treating HIV
↗
November 13, 2025
The company now plans to submit the data from the study to regulatory authorities.
Via
Stocktwits
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session.
↗
November 13, 2025
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Via
Chartmill
Pfizer CEO Sees Metsera’s Drugs Hit Market As Early As 2028 After Completing Acquisition: Report
↗
November 13, 2025
CEO Albert Bourla told Yahoo Finance that the acquisition of GLP-1 maker Metsera is part of the company's "right to win" in the obesity drug game.
Via
Stocktwits
Pfizer Completes Acquisition of Metsera
November 13, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run
↗
November 13, 2025
Pfizer plans to sell its remaining BioNTech stake through a $508 million block trade, ending a profitable Covid-19 vaccine partnership.
Via
Benzinga
BioNTech Says Collaboration With Pfizer Going Strong After Report Indicated US Pharma Giant Considering Stake Sale In The German Company
↗
November 13, 2025
A BioNTech spokesperson told Reuters that the two companies continue to have a “close and strong collaboration.”
Via
Stocktwits
Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?
↗
November 13, 2025
Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.
Via
The Motley Fool
Topics
Intellectual Property
Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play
↗
November 13, 2025
Canaccord said Viking’s obesity pipeline is worth far more than the current valuation.
Via
Stocktwits
Reflecting On Generic Pharmaceuticals Stocks’ Q3 Earnings: Viatris (NASDAQ:VTRS)
November 12, 2025
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Viatris (NASDAQ:VTRS) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
3 Healthcare Stocks Topping a 2025 List of Dividend Yields
↗
November 12, 2025
Turn health into wealth with these three high-yielding dividend stocks.
Via
The Motley Fool
Curious about the most active S&P500 stocks in today's session?
↗
November 12, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the most active S&P500 stocks in today's session.
Via
Chartmill
Dow Soars to New Record High as Government Shutdown Nears End
November 12, 2025
New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) surged by nearly 400 points today, hitting an unprecedented record high, as investors enthusiastically embraced the impending...
Via
MarketMinute
Topics
Economy
Government
Stocks
Looking Into Pfizer Inc's Recent Short Interest
↗
November 12, 2025
Via
Benzinga
Eledon Pharmaceuticals Stock Plunges Following $50 Million Public Offering
November 12, 2025
Irvine, CA – November 12, 2025 – Eledon Pharmaceuticals (NASDAQ: ELDN) witnessed a significant decline in its stock value today, plummeting by 17.8% in premarket trading. This sharp drop comes on the...
Via
MarketMinute
Topics
Initial Public Offering
Intellectual Property
Regulatory Compliance
2 Strong Healthcare Stock Picks for Value Investors
↗
November 12, 2025
Value-driven plays abound in the top healthcare stocks.
Via
The Motley Fool
Topics
Intellectual Property
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 12, 2025
From
Pfizer Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.